FILTRATION FOR FREE DRUG LEVEL MONITORING - CARBAMAZEPINE AND VALPROIC ACID

被引：35

作者：

LEVY, RH

FRIEL, PN

JOHNO, I

LINTHICUM, LM

COLIN, L

KOCH, K

RAISYS, VA

WILENSKY, AJ

TEMKIN, NR

机构：

[1] UNIV WASHINGTON,SCH MED,CTR EPILEPSY,DEPT NEUROL SURG,SEATTLE,WA 98195

[2] UNIV WASHINGTON,SCH MED,DEPT LAB MED,SEATTLE,WA 98195

[3] UNIV WASHINGTON,SCH PUBL HLTH,DEPT BIOSTAT,SEATTLE,WA 98195

[4] SYVA CO,PALO ALTO,CA

来源：

THERAPEUTIC DRUG MONITORING | 1984年 / 6卷 / 01期

关键词：

D O I：

10.1097/00007691-198403000-00012

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：67 / 76

页数：10

共 21 条

[1]

[Anonymous], [No title captured]

[2]

BEHM HL, 1979, RES COMMUN CHEM PATH, V26, P145

[3] VALPROIC ACID DOSAGE AND PLASMA-PROTEIN BINDING AND CLEARANCE [J].

BOWDLE, TA ;

PATEL, IH ;

LEVY, RH ;

WILENSKY, AJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (04) :486-492

[4] VALPROIC ACID - INVITRO PLASMA-PROTEIN BINDING AND INTERACTION WITH PHENYTOIN [J].

CRAMER, JA ;

MATTSON, RH .

THERAPEUTIC DRUG MONITORING, 1979, 1 (01) :105-116

[5]

CRONIN M, 1982, Clinical Pharmacology and Therapeutics, V31, P214

[6] VALPROIC ACID PHENYTOIN INTERACTION [J].

FRIEL, PN ;

LEAL, KW ;

WILENSKY, AJ .

THERAPEUTIC DRUG MONITORING, 1979, 1 (02) :243-248

[7] PLASMA-PROTEIN BINDING OF VALPROIC ACID IN HEALTHY SUBJECTS AND IN PATIENTS WITH RENAL-DISEASE [J].

GUGLER, R ;

MUELLER, G .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (05) :441-446

[8]

HOOPER WD, 1975, CLIN PHARMACOL THER, V17, P433

[9]

JOERN WA, 1981, CLIN CHEM, V27, P417

[10] MONITORING OF FREE VALPROIC ACID LEVELS [J].

LEVY, RH .

THERAPEUTIC DRUG MONITORING, 1980, 2 (02) :199-201

← 1 2 3 →